Embase

Same, same premise.

A comprehensive search across PubMed and Embase databases was conducted, uh, from the beginning of the study through November of 2025.

I don't know when the study began.

Eligibility criteria for inclusion were, one, exposure to GLP-1 before or during gestation.

We need to understand the traceability, we need to understand where is information coming from, seeing annotations, and also ensuring at the same time that the systems are designed in a way that we can actually use them also in a compliant way.

So for example, If we use Copilot and it only accesses our SharePoint, but our content is maybe stored somewhere in Viva or in our Embase or somewhere else, how should the system also create the right output, right? I think that's also another one that we see this a lot in organizations.

The system, the bias that is already set up basically by design in the systems.

And the other part is also really by design, thinking through in which steps... um the user needs to have better oversight and understanding i love what michelle said earlier that the expert takes the decisions and the tool should help in the execution but then you also need to allow the user actually to take the right decisions at the right step of the workflow and the other part compliance is obviously super important we're also working with um copyright protected data and ensuring that we can also in the process basically work compliant, I think is also responsibility towards the experts in your organization because they have the pressure to be faster, but then they also require basically systems that can actually work in a compliant way.

On the other hand, plenty of benefits are clearly linked to sun exposure, and Ziegler et al.

addressed this in their review article entitled "Systemic Effects of Sunlight: 10-Year Review of Cardiovascular, Infection, and Cancer Outcomes." And here they basically try to answer the question: Does sunlight kill you or does it secretly keep you alive? What did they do? Well, they searched in PubMed and Embase, identified one hundred and forty-eight articles, screened those article, and ended up with 28 relevant studies.

Four main topics.

First one, cardiovascular outcomes, then infectious disease, malignancies, and then also all-cause mortality.

Um, [clears throat] "Methods.

We conducted an extensive search of PubMed, Cochrane, and Embase databases up to March 2024, identifying circumstances where associations from observational studies were incorrectly deemed causal.

These instances led to changes in clinical practice embodying what we have termed the observational interpretation fallacy." You with me so far, folks? So, "Our results identified 16 notable cases." Now, as I say, I have not read the paper, so I don't know what the 16 notable cases [laughs] were.

They may have been about fatphobia.

So yes, it was quite unique in that sense, like you said, Catherine, about how it's focusing on diagnostic accuracy rather than treatments or outcomes.

So it was a-- They undertook a search of the trials and publications, uh, as well as unpublished data, um, from many different databases, Central, Medline, Embase, websites, and as well as clinical trials that were registered on clinicaltrials.gov and the WHO International Clinical Trials Registry.

And this search was current to quite recent, the, in May 2024.

I found it unique that they didn't have any language restrictions or publication status restrictions.

This review was performed to study the efficacy and safety of PRP in women suffering from female sexual dysfunction and stress urinary incontinence, either or, and to explore the optimal dosing frequency and area of injections or the duration of treatment.

So they performed a systematic search on PubMed, Embase, and the Cochrane Library database up to January of 2023.

They found four prospective and one retrospective study that explored female sexual dysfunction.

A total of 327 women with a mean age of 51 plus minus 12 years were included in these studies.

It emphasizes that neck aging is multifactorial and requires treatment tailored to the underlying anatomy.

The authors searched Medline, Embase, and Web of Science and identified 1,225 studies, of which 451 studies were considered relevant.

The review categorizes treatments into injectables, energy-based devices, mechanical stimulation, and liposuction.

For injectables, deoxycholic acid targets submental fat with one study reporting reduction in 91.7% of patients after two treatments with effects sustained for up to two years.

This systematic review and meta-analysis followed the PRISMA Twenty Twenty guidelines.

We searched PubMed, Scopus, Web of Science, and Embase from database inception until December of twenty twenty-five, uh, for studies evaluating the outcomes of ESD for locally recurrent gastric neoplasia after endoscopic resection.

We included, uh, s-retrospective and prospective studies, whether as full text articles or as conference abstracts, as long as they reported, uh, outcome data for ESD in these clinical settings.

We excluded articles that, uh, evaluated, evaluated ESD for submucosal lesions, articles where the initial, uh, resection technique was surgical, and articles where the salvage resection technique was another endoscopic resection technique, such as EMR.